Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis

Published: 13 December 2022| Version 6 | DOI: 10.17632/76czfxgmvb.6
Contributors:
Yuanyuan Xu,
Zhixuan Li,
Shuwei Wu,
Linghong Guo,
Xian Jiang

Description

This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment choice for children and adolescents with AD. More long-term, high-quality, controlled studies in different regions are in demand for further verification.

Files

Categories

Dermatology

License